Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name AGX148
Trade Name
Synonyms AGX 148|AGX-148
Drug Descriptions

AGX148 are autologous patient-derived CD8-positive tumor infiltrating lymphocytes (TILs) that have been selected for the expression of CD103 and CD39, which potentially induce tumor cell death and decrease tumor growth (J Immunol (2022) 208 (1_Supplement): 117.06).

CAS Registry Number NA


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
AGX148 AGX148 0 0
AGX148 + Aldesleukin AGX148 Aldesleukin 0 1

Additional content available in CKB BOOST